34298 Federal Register / Vol. 87, No. 108 / Monday, June 6, 2022 / Notices 

determined to review various findings 

in the ID. 83 FR 63672 (Dec. 11, 2018). 

On December 18, 2019, the 

Commission found a violation of section 

337 with respect to the ’664, ’682, and 

’635 patents. 84 FR 70999 (Dec. 26, 

2019). The Commission also found no 

violation of section 337 with respect to 

the ’160 patent. Id. The Commission 

determined to issue a limited exclusion 

order prohibiting further importation of 

10X’s infringing microfluidic devices 

and a cease and desist order (‘‘CDO’’) 

against 10X. Id. 

On May 28, 2021, in an appeal 

initiated by Bio-Rad, the U.S. Court of 

Appeals for the Federal Circuit issued a 

decision affirming the Commission’s 

final determination. Bio-Rad Labs., Inc. 

v. Int’l Trade Comm’n, 998 F.3d 1320 

(Fed. Cir. 2021). 

On July 26, 2021, Bio-Rad and 10X 

entered into a settlement agreement that 

resolved the disputes concerning the 

subject matter of this investigation. 

On July 28, 2021, Bio-Rad and 10X 

jointly petitioned for rescission of the 

Commission’s remedial orders under 

section 337(k) (19 U.S.C. 1337(k)) and 

Commission Rule 210.76(a) (19 CFR 

210.76(a)). On August 25, 2021, the 

Commission granted the parties’ 

petition and rescinded the remedial 

orders. 

On July 27, 2021, 10X filed a motion 

for return of the bond it posted pursuant 

to the CDO entered in this investigation. 

On August 6, 2021, OUII filed a 

response supporting the motion. 

On April 13, 2022, the ALJ issued 

Order No. 37, the subject ID, which 

granted the motion. The ALJ found that 

10X satisfied the procedural 

requirements for the return of bond, that 

the settlement agreement between BioRad and 10X resolved the dispute 

between them regarding activities 

during the period of Presidential review 

that were subject to the Commission’s 

remedial orders, and that the 

Commission has previously released the 

respondent’s bond under similar 

circumstances. 

No party filed a petition for review of 

the subject ID. 

The Commission has determined not 

to review the subject ID. 

The Commission vote for this 

determination took place on May 31, 

2022. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in part 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: May 31, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–12024 Filed 6–3–22; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 731–TA–1082–1083 

(Third Review)] 

Chlorinated Isocyanurates From China 

and Spain; Scheduling of Full FiveYear Reviews 

AGENCY: United States International 

Trade Commission. 

ACTION: Notice. 

SUMMARY: The Commission hereby gives 

notice of the scheduling of full reviews 

pursuant to the Tariff Act of 1930 (‘‘the 

Act’’) to determine whether revocation 

of the antidumping duty orders on 

chlorinated isocyanurates from China 

and Spain would be likely to lead to 

continuation or recurrence of material 

injury within a reasonably foreseeable 

time. The Commission has determined 

to exercise its authority to extend the 

review period by up to 90 days. 

DATES: May 31, 2022. 

FOR FURTHER INFORMATION CONTACT: 

Keysha Martinez (202–205–2136), Office 

of Investigations, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436. Hearingimpaired persons can obtain 

information on this matter by contacting 

the Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server (https://

www.usitc.gov). The public record for 

these reviews may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. 

SUPPLEMENTARY INFORMATION: 

Background.—On January 4, 2022, the 

Commission determined that responses 

to its notice of institution of the subject 

five-year reviews were such that full 

reviews should proceed (87 FR 4290, 

January 27, 2022); accordingly, full 

reviews are being scheduled pursuant to 

section 751(c)(5) of the Tariff Act of 

1930 (19 U.S.C. 1675(c)(5)). A record of 

the Commissioners’ votes, the 

Commission’s statement on adequacy, 

and any individual Commissioner’s 

statements are available from the Office 

of the Secretary and at the 

Commission’s website. 

Participation in the reviews and 

public service list.—Persons, including 

industrial users of the subject 

merchandise and, if the merchandise is 

sold at the retail level, representative 

consumer organizations, wishing to 

participate in these reviews as parties 

must file an entry of appearance with 

the Secretary to the Commission, as 

provided in section 201.11 of the 

Commission’s rules, by 45 days after 

publication of this notice. A party that 

filed a notice of appearance following 

publication of the Commission’s notice 

of institution of the reviews need not 

file an additional notice of appearance. 

The Secretary will maintain a public 

service list containing the names and 

addresses of all persons, or their 

representatives, who are parties to the 

reviews. 

For further information concerning 

the conduct of these reviews and rules 

of general application, consult the 

Commission’s Rules of Practice and 

Procedure, part 201, subparts A and B 

(19 CFR part 201), and part 207, 

subparts A, D, E, and F (19 CFR part 

207). 

Please note the Secretary’s Office will 

accept only electronic filings during this 

time. Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://

edis.usitc.gov.) No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. 

Limited disclosure of business 

proprietary information (BPI) under an 

administrative protective order (APO) 

and BPI service list.—Pursuant to 

section 207.7(a) of the Commission’s 

rules, the Secretary will make BPI 

gathered in these reviews available to 

authorized applicants under the APO 

issued in the reviews, provided that the 

application is made by 45 days after 

publication of this notice. Authorized 

applicants must represent interested 

parties, as defined by 19 U.S.C. 1677(9), 

who are parties to the reviews. A party 

granted access to BPI following 

publication of the Commission’s notice 

of institution of the reviews need not 

reapply for such access. A separate 

service list will be maintained by the 

Secretary for those parties authorized to 

receive BPI under the APO. 

Staff report.—The prehearing staff 

report in the reviews will be placed in 

the nonpublic record on September 12, 

2022, and a public version will be 

issued thereafter, pursuant to section 

207.64 of the Commission’s rules. 

Hearing.— The Commission will hold 

a hearing in connection with the 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 108 / Monday, June 6, 2022 / Notices 34299 

reviews beginning at 9:30 a.m. on 

September 29, 2022. Information about 

the place and form of the hearing, 

including about how to participate in 

and/or view the hearing, will be posted 

on the Commission’s website at https:// 

www.usitc.gov/calendarpad/ 

calendar.html. Interested parties should 

check the Commission’s website 

periodically for updates. Requests to 

appear at the hearing should be filed in 

writing with the Secretary to the 

Commission on or before September 22, 

2022. A nonparty who has testimony 

that may aid the Commission’s 

deliberations may request permission to 

present a short statement at the hearing. 

All parties and nonparties desiring to 

appear at the hearing and make oral 

presentations should attend a 

prehearing conference to be held at 9:30 

a.m. on September 23, 2022. Oral 

testimony and written materials to be 

submitted at the public hearing are 

governed by sections 201.6(b)(2), 

201.13(f), and 207.24 of the 

Commission’s rules. Parties must submit 

any request to present a portion of their 

hearing testimony in camera no later 

than 7 business days prior to the date of 

the hearing. 

Written submissions.—Each party to 

the reviews may submit a prehearing 

brief to the Commission. Prehearing 

briefs must conform with the provisions 

of section 207.65 of the Commission’s 

rules; the deadline for filing is 

September 20, 2022. Parties may also 

file written testimony in connection 

with their presentation at the hearing, as 

provided in section 207.24 of the 

Commission’s rules, and posthearing 

briefs, which must conform with the 

provisions of section 207.67 of the 

Commission’s rules. The deadline for 

filing posthearing briefs is October 7, 

2022. In addition, any person who has 

not entered an appearance as a party to 

the reviews may submit a written 

statement of information pertinent to 

the subject of the reviews on or before 

October 7, 2022. On November 1, 2022, 

the Commission will make available to 

parties all information on which they 

have not had an opportunity to 

comment. Parties may submit final 

comments on this information on or 

before November 3, 2022, but such final 

comments must not contain new factual 

information and must otherwise comply 

with section 207.68 of the Commission’s 

rules. All written submissions must 

conform with the provisions of section 

201.8 of the Commission’s rules; any 

submissions that contain BPI must also 

conform with the requirements of 

sections 201.6, 207.3, and 207.7 of the 

Commission’s rules. The Commission’s 

Handbook on Filing Procedures, 

available on the Commission’s website 

at https://www.usitc.gov/documents/ 

handbook_on_filing_procedures.pdf, 

elaborates upon the Commission’s 

procedures with respect to filings. 

Additional written submissions to the 

Commission, including requests 

pursuant to section 201.12 of the 

Commission’s rules, shall not be 

accepted unless good cause is shown for 

accepting such submissions, or unless 

the submission is pursuant to a specific 

request by a Commissioner or 

Commission staff. 

In accordance with sections 201.16(c) 

and 207.3 of the Commission’s rules, 

each document filed by a party to the 

reviews must be served on all other 

parties to the reviews (as identified by 

either the public or BPI service list), and 

a certificate of service must be timely 

filed. The Secretary will not accept a 

document for filing without a certificate 

of service. 

The Commission has determined that 

these reviews are extraordinarily 

complicated and therefore has 

determined to exercise its authority to 

extend the review period by up to 90 

days pursuant to 19 U.S.C.1675(c)(5)(B). 

Authority: These reviews are being 

conducted under authority of title VII of 

the Tariff Act of 1930; this notice is 

published pursuant to section 207.62 of 

the Commission’s rules. 

By order of the Commission. 

Issued: May 31, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–12023 Filed 6–3–22; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1316] 

Certain Pneumatic Compression 

Devices and Components Thereof; 

Institution of Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that a 

complaint was filed with the U.S. 

International Trade Commission on 

April 29, 2022, under section 337 of the 

Tariff Act of 1930, as amended, on 

behalf of Precision Holdings USA Inc. of 

Rocklin, California and Innovamed 

Health LLC of San Antonio, Texas. 

Supplements were filed on May 9, 2022, 

and May 11, 2022. The complaint, as 

supplemented, alleges violations of 

section 337 based upon the importation 

into the United States, the sale for 

importation, and the sale within the 

United States after importation of 

certain pneumatic compression devices 

and components thereof by reason of 

infringement of certain claims of U.S. 

Patent No. 10,058,475 (‘‘the ’475 

patent’’) and U.S. Patent No. 10,912,704 

(‘‘the ’704 patent’’). The complaint 

further alleges that an industry in the 

United States exists as required by the 

applicable Federal Statute. The 

complainant requests that the 

Commission institute an investigation 

and, after the investigation, issue a 

limited exclusion order and cease and 

desist orders. 

ADDRESSES: The complaint, except for 

any confidential information contained 

therein, may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. Hearing impaired 

individuals are advised that information 

on this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. Persons 

with mobility impairments who will 

need special assistance in gaining access 

to the Commission should contact the 

Office of the Secretary at (202) 205– 

2000. General information concerning 

the Commission may also be obtained 

by accessing its internet server at 

https://www.usitc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Pathenia M. Proctor, The Office of 

Unfair Import Investigations, U.S. 

International Trade Commission, 

telephone (202) 205–2560. 

SUPPLEMENTARY INFORMATION: 

Authority: The authority for 

institution of this investigation is 

contained in section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 

1337, and in section 210.10 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10 (2022). 

Scope of Investigation: Having 

considered the complaint, the U.S. 

International Trade Commission, on 

May 31, 2022, ordered that— 

(1) Pursuant to subsection (b) of 

section 337 of the Tariff Act of 1930, as 

amended, an investigation be instituted 

to determine whether there is a 

violation of subsection (a)(1)(B) of 

section 337 in the importation into the 

United States, the sale for importation, 

or the sale within the United States after 

importation of certain products 

identified in paragraph (2) by reason of 

infringement of one or more of claims 

16–18 of the ’475 patent and claims 1, 

3, 4, 11–15, and 18–20 of the ’704 

patent, and whether an industry in the 


lotter on DSK11XQN23PROD with NOTICES1